spacer
home > ict > autumn 2016 > future vision
PUBLICATIONS
International Clinical Trials

Future Vision

Over the past few years, certain factors have contributed to a rising trend of trial supply sourcing: an increase of studies being conducted, reduced start-up timelines, patient recruitment issues, globalisation and the escalating costs for investigational drugs and comparators. Is it even possible to predict the precise number of supplies needed to run a trial efficiently?

Looking Ahead


One option may be the use of forecasting and simulations. Consider a weather forecast, for instance: weathermen will predict high and low temperatures, humidity level, air pressure and other elements based on a number of factors. Different weather models will generally produce similar – but not identical – predictions, shown by minor variations in forecasts from different weather stations. Also, as you look further into the future, the predictions of each model will vary more and reliability will be reduced. This is why, if you are anticipating an event, it is necessary to check weather forecasts regularly as the day of the event approaches.

This is also the case with trial supply forecasts. Forecasting refers to techniques used to predict future outcomes, on the basis of past events and professional insights gained from observation. Methods usually rely on mathematical formulas based on facts, perceived trends, data models and, at times, expert opinions. While it is impossible to know the results of a clinical trial ahead of time with absolute certainty, forecasting provides sponsors with data-driven decisions when planning, running and closing a study.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Praveen Chand is the Director of Professional Services and Clinical Analytics at Cenduit. He brings over 15 years of technology consulting and innovations experience, with a primary focus on pharma and life sciences translational research in clinical trials and drug development. Praveen holds an MS in Computer Science and Engineering, and a BS in Electronics and Instrumentation from GJ University of Science and Technology in Hisar, India.
spacer
Praveen Chand
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Registration Opens for Inaugural HPAPI USA Conference in October

The HPAPI global market is growing at an ever-increasing rate of CAGR at 8.6% that is projected to reach USD $31.56 Billion by 2025, with a significant segment market of HPAPI being oncology ADC which is at a CARG of a staggering 20%. The continual elevation of HPAPI potencies along with toxicity will further drive the needs for more cutting-edge containment solutions and best practices guidelines to ensure workers safety.
More info >>

White Papers

Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models

DrugDev

For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality. One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>

 
Industry Events

World Pharma Week 2019

17-20 June 2019, Seaport World Trade Center, Boston

World Pharma Week will bring together a unique and international mix of large and medium pharmaceutical and biotech companies, CROs, leading universities and clinical research institutions, emerging companies and tool providers—making it a perfect meeting-place to share experience, foster collaborations across industry and academia, and evaluate emerging technologies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement